The significance of NMO-IgG positivity in neuromyelitis optica spectrum disorders: preliminary results

被引：0
|
作者：
Altintas, A. [1 ]
Nalbantoglu, M. [1 ]
Celik, R. G. Gozubatik [1 ]
Adibnia, Y. [2 ]
Kursun, A. [3 ]
Deniz, G. [3 ]
机构：
[1] Istanbul Univ, Cerrahpasa Med Fac, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Med Sch, Istanbul, Turkey
[3] Istanbul Univ, Inst Expt Med, Istanbul, Turkey
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：752 / 752
页数：1
相关论文
共 50 条
  • [21] Neuromyelitis optica (NMO) in naive rats produced by intracerebral or intraperitoneal administration of NMO-IgG
    Asavapanumas, N.
    Ratelade, J.
    Verkman, A. S.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 47 - 47
  • [22] Revised diagnostic criteria for neuromyelitis optica—incorporation of NMO-IgG status
    Sven Jarius
    Friedemann Paul
    Diego Franciotta
    Orhan Aktas
    Reinhard Hohlfeld
    Frauke Zipp
    Angela Vincent
    Nature Clinical Practice Neurology, 2007, 3 : E1 - E1
  • [23] NMO-IgG detection in Brazilian patients with neuromyelitis optica: First report
    Adoni, T.
    Marchiori, P. E.
    Lino, A. M.
    Callegaro, D.
    MULTIPLE SCLEROSIS, 2007, 13 : S111 - S112
  • [24] NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy
    Kay, Claudia S. K.
    Scola, Rosana H.
    Lorenzoni, Paulo J.
    Jarius, Sven
    Arruda, Walter O.
    Werneck, Lineu C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 275 (1-2) : 148 - 150
  • [25] Revised diagnostic criteria for neuromyelitis optica - Incorporation of NMO-IgG status
    Jarius, Sven
    Paul, Friedemann
    Franciotta, Diego
    Aktas, Orhan
    Hohlfeld, Reinhard
    Zipp, Frauke
    Vincent, Angela
    NATURE CLINICAL PRACTICE NEUROLOGY, 2007, 3 (05): : E1 - E1
  • [26] Rituximab for neuromyelitis optica: experience with nine NMO-IgG positive patients
    Brown, A. D.
    Delgado, S.
    Sheremata, W. A.
    MULTIPLE SCLEROSIS, 2007, 13 (09): : 1221 - 1221
  • [27] The clinical and prognostic value of antinuclear antibodies in NMO-IgG seropositive neuromyelitis optica spectrum disorder
    Lee, Eun-Jae
    Lim, Young-Min
    Kim, Sun-Young
    Lee, JooKyung
    Kim, Hyunjin
    Jin, Joo Yea
    Oh, Yeo Jin
    Kim, Kwang-Kuk
    JOURNAL OF NEUROIMMUNOLOGY, 2019, 328 : 1 - 4
  • [28] Seroprevalence of NMO-IgG in multiple sclerosis with opticospinal presentation and neuromyelitis optica
    Maghzi, A. H.
    Mollabashi, M.
    Etemadifar, M.
    MULTIPLE SCLEROSIS, 2010, 16 (10): : 1288 - 1288
  • [29] NMO-IgG antibody in Neuromyelitis optica: sensitivity and specificity in Iranian patients
    Harirchian, M. H.
    Shasia, R.
    Tafakhri, A.
    Mohammadi, F.
    Aghamolaee, V.
    JOURNAL OF NEUROLOGY, 2012, 259 : S152 - S152
  • [30] Coincidence of highly specific NMO-IgG antibodies in neuromyelitis optica with other autoimmune disorders and/or antibodies
    Nytrova, P.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S36 - S36
12345